Leerink Partnrs Lowers Earnings Estimates for HCA Healthcare

HCA Healthcare, Inc. (NYSE:HCAFree Report) – Investment analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of HCA Healthcare in a research note issued on Monday, January 27th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $5.80 per share for the quarter, down from their previous estimate of $6.08. The consensus estimate for HCA Healthcare’s current full-year earnings is $21.75 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q2 2025 earnings at $6.37 EPS, Q3 2025 earnings at $5.55 EPS, Q4 2025 earnings at $7.39 EPS, FY2025 earnings at $25.11 EPS, Q1 2026 earnings at $6.86 EPS, Q2 2026 earnings at $7.19 EPS, Q3 2026 earnings at $6.28 EPS, Q4 2026 earnings at $8.44 EPS and FY2026 earnings at $28.78 EPS.

Several other equities analysts have also recently weighed in on HCA. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Barclays dropped their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Oppenheimer lifted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $382.19.

Check Out Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Down 0.3 %

HCA Healthcare stock opened at $327.80 on Tuesday. The company has a 50 day moving average of $313.28 and a 200-day moving average of $353.27. HCA Healthcare has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market capitalization of $83.03 billion, a PE ratio of 14.72, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the firm posted $5.90 EPS.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.88%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insiders Place Their Bets

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently modified their holdings of HCA. Avestar Capital LLC grew its position in shares of HCA Healthcare by 27.5% in the 4th quarter. Avestar Capital LLC now owns 1,149 shares of the company’s stock valued at $345,000 after buying an additional 248 shares during the last quarter. Gladstone Institutional Advisory LLC increased its position in HCA Healthcare by 43.4% during the 4th quarter. Gladstone Institutional Advisory LLC now owns 859 shares of the company’s stock valued at $258,000 after purchasing an additional 260 shares during the period. Sovran Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $990,000. Compound Global Advisors LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $1,111,000. Finally, Summit Trail Advisors LLC boosted its position in HCA Healthcare by 9.7% during the fourth quarter. Summit Trail Advisors LLC now owns 3,964 shares of the company’s stock valued at $1,190,000 after acquiring an additional 352 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.